TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT07334691
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Cardiovalve Ltd.
- Registry
-
NCT07334691
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT07334691. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-20 (actual); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
- Condition
- Tricuspid Regurgitation
- Intervention (Device)
- Cardiovalve TR valve replacement System
- Lead sponsor
- Cardiovalve Ltd.
Record details
- Record id
cardio:ct-nct07334691- Content hash
3cef1244368115c2dacdd6227415a0f5506944b35d361cf1f060248981249d38